FRVAX (FRVAX) Stock Price & Analysis
FRVAX (FRVAX) rose 0.00% to USD 9.68 as of September 9, 2026 at 18:29 UTC, according to Nexqual real-time market data.
FRVAX last closed at USD 9.68; the session ranged USD 9.68–9.68 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 9.68–10.02 (NAS). Source: Nexqual, September 9, 2026 at 18:29 UTC.
Key Statistics (as of September 9, 2026 at 18:29 UTC)
| Price | USD 9.68 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 9.68 |
| Open | USD 9.68 |
| Day Range | USD 9.68 – 9.68 |
| 52-Week Range | USD 9.68 – 10.02 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (FRVAX)
Nexqual's technical model rates FRVAX "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 18:29 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 21.3 (oversold) |
| vs SMA50 | Below (USD 9.85) |
| MACD | -0.05 (negative) |
Financial Health Score (FRVAX)
Nexqual rates FRVAX's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 18:29 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LIBAX | Columbia Total Return Bond Fund | USD 29.83 | ▼ 0.1% |
| GLCGX | Goldman Sachs Large Cap Growth | USD 33.03 | ▼ 0.48% |
| FRPAX | Franklin Pennsylvania Tax-Free | USD 8.52 | ▲ 0% |
| FRCOX | Franklin Colorado Tax-Free Inco | USD 10.27 | ▼ 0.1% |
| FRORX | Franklin Oregon Tax-Free Income | USD 10.16 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 18:29 UTC. This page is informational and not investment advice.